The impact and acceptability of a multimorbidity pharmaceutical care planning checklist in primary care

Wendy Carswel, Anne Kinnear , Amanj Kurdi, Karen Reid

Research output: Contribution to conferenceAbstractpeer-review

24 Downloads (Pure)

Abstract

Background and Objective: Polypharmacy review is a key role for primary care pharmacists in Scotland.1 Pharmacists' ability to identify care issues can vary.2,3 In response to this, two Advanced Clinical Pharmacists in NHS Lothian, with input from specialist teams, have developed an evidence based, multimorbidity checklist for pharmaceutical care planning. The checklist, covering 13 common chronic conditions, lists potential care issues with standardised actions to optimise patient care and reduce harm. The aim of this study was to assess whether the checklist could improve the identification of pharmaceutical care issues and to evaluate its acceptability.
Original languageEnglish
Number of pages1
Publication statusPublished - 22 Oct 2022
EventThe 50th European Symposium of Clinical Pharmacy - Prague, Czech Republic
Duration: 19 Oct 202221 Oct 2022

Conference

ConferenceThe 50th European Symposium of Clinical Pharmacy
Abbreviated titleESCP2022
Country/TerritoryCzech Republic
CityPrague
Period19/10/2221/10/22

Keywords

  • multimorbidity
  • pharmaceutical care
  • primary care

Fingerprint

Dive into the research topics of 'The impact and acceptability of a multimorbidity pharmaceutical care planning checklist in primary care'. Together they form a unique fingerprint.

Cite this